Confidence that's quantifiable

In addition to tracer development and production, and premium imaging technology, our end-to-end advanced molecular imaging solution now offers our most advanced and comprehensive processing, analytics, and advanced AI-powered workflows available in the market. This allows us to fully deliver on our commitment to support personalized precision care to help improve patient outcomes.
MIM Encore
MIM SurePlan MRT
LesionID Pro
MIMneuro

MIM Encore

Consolidate PET and SPECT image processing with MIM Encore, a single solution tightly integrated into GE HealthCare’s molecular imaging (MI) precision care portfolio. Whether imaging on a StarGuide, Omni, Aurora, Discovery MI, or any scanner in the clinic, MIM Encore handles image processing within a single solution.

Comprehensive imaging solution

Advanced visualization, post-processing, reporting, and workflow automation.

Drive flexible workflows

Streamline and standardize processes with configurable guided workflows.

Precise quantitation

Gain new quantitative insights with versatile reconstruction, automation, and display options.

Versatile deployment

Deploy and scale thick and thin clients with flexible licensing options

Schedule a demo

MIM SurePlan MRT

Streamline and standardize dosimetry workflows with automated reconstruction, segmentation, and dose calculation.

Quantitative reconstruction

Standardize and automate SPECT reconstruction

Accurate dosimetry

Easily estimate absorbed dose with practical imaging protocols

Simple segmentation

Enable time saving with advanced AI-based segmentation for normal structures

Dosimetry reporting

Configure structured reports and deform dose accumulation automatically

Schedule a demo

LesionID Pro

Aid decision making without increasing workload. LesionID Pro gives clinicians time-saving tools to extract quantitative patient-specific insights from PSMA PET/CT and SPECT/CT studies, aiding in assessing tumor burden during planning and evaluation of treatment options, such as radiopharmaceutical therapy (RPT)

LesionID Pro for PSMA PET/CT

Aid treatment decision making with efficient whole-body lesion segmentation and automated calculation of total tumor burden.

LesionID Pro for PSMA SPECT/CT

Aid treatment response monitoring with efficient whole-body lesion segmentation, and automated total tumor burden calculation and tracking.

AI-Powered Contouring

LesionID Pro streamlines PSMA PET/CT and SPECT/CT analysis with AI-powered contouring, and tumor burden reporting.

Schedule a demo

MIMneuro

Visualize and quantify uptake in PET and SPECT brain imaging. multi-tracer support, intuitive visualization, quick quantitative analysis, and automated reporting give your team the tools you need for a confident assessment.

Centiloid scaling

Easy access to the quantitative analysis for confident assessment

Multi-tracer support

Supports a variety of PET and SPECT tracers for confident assesment

Advanced analysis

Voxel-based, cluster, and region-based analysis for enhanced quantitation

Schedule a demo

An aligned all-in-one customer experience

We offer an all-in-one package to streamline clinical workflows across pharmaceuticals, imaging and image processing.
The seamless fusion of imaging technology with advanced AI-driven analytics means healthcare providers will have precise tools to visualize, diagnose, and monitor patient conditions, to helping make a positive impact on the future of patient-centered care.

Effortlessly adaptable workflow

GE HealthCare's automated, AI-powered Effortless Workflow includes comprehensive and flexible pre-scan, scanning, and post-processing solutions for both PET and SPECT.

Accurate precision quantitation

Our advanced quantitative reconstruction and segmentation help ensure you have the right data to make confident decisions about patient, dosimetry and treatment management.

A platform empowered to discover what lies ahead

GE HealthCare’s advanced, research-assisting portfolios grow with your clinic’s future needs and empower researchers of tomorrow’s nuclear medicine to accelerate and lead innovation. Our aligned vision and roadmap, combined with our flexible workflows position us as a leading choice to support your complex research needs.

Have a question? We would love to hear from you. 

JB33595XX